Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK's MMRV vaccine immunogenicity and safety in healthy children
NCT00126997Phase 4Completed
- Sponsor
- GSK
- Start
- May 2005
- Primary completion
- Nov 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 4 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started May 2005; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00126997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126997.